Neurocrine Biosciences (NBIX) Net margin US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Net margin, % | ? | 4.69% | 38.9% | 7.90% | 10.4% | 13.2% | 17.2% | ||
Changes by years, y/y, % | +0pp | +34pp | -31pp | +2pp | +3pp | +23.1% |
Neurocrine Biosciences. Net margin, %
Neurocrine Biosciences. Net margin, changes, pp
Neurocrine Biosciences (NBIX) Net margin US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
Net margin, % | ? | 16.7% | 28.7% | 8.42% | 11.0% | 20.9% | 17.2% | |
Changes by years, y/y, % | -1pp | +7pp | +27pp | -10pp | +4pp | |||
Changes by quarters, q/q, % | -4pp | +12pp | -20pp | +3pp | +10pp |